Cargando…
Eribulin-induced Interstitial Pneumonia: A Case Series and Retrospective Cohort Study
Eribulin is a chemotherapeutic agent used for advanced breast cancer, but there are some reports of eribulin-induced lung injuries. Three of our patients experienced eribulin-related lung injuries. Radiology revealed organizing pneumonia in two cases and diffuse ground-glass shadows indicative of hy...
Autores principales: | Murakami, Manabu, Kanemura, Hiroaki, Tomishima, Yutaka, Nakano, Eriko, Tamura, Tomohide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056385/ https://www.ncbi.nlm.nih.gov/pubmed/31588076 http://dx.doi.org/10.2169/internalmedicine.2779-19 |
Ejemplares similares
-
Development of interstitial pneumonia during treatment with eribulin: a case report
por: Nakamura, Kota, et al.
Publicado: (2017) -
Pectoralis Muscle Mass on Chest CT at Admission Predicts Prognosis in Patients with Pneumonia
por: Yokosuka, Ryohsuke, et al.
Publicado: (2021) -
Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy
por: Ro, Shosei, et al.
Publicado: (2021) -
Digital Clubbing Is Associated with Higher Serum KL-6 Levels and Lower Pulmonary Function in Patients with Interstitial Lung Disease
por: Shiraishi, Kazushige, et al.
Publicado: (2018) -
Yellow Nail Syndrome Patients with Diffuse Panbronchiolitis-like Pulmonary Manifestation
por: Imai, Ryosuke, et al.
Publicado: (2018)